0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Active Vitamin D Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-0W17052
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Active Vitamin D Market Research Report 2024
BUY CHAPTERS

Global Active Vitamin D Market Research Report 2024

Code: QYRE-Auto-0W17052
Report
March 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Active Vitamin D Market

Vitamin D3 itself has no physiological activity. It needs to be hydroxylated by 25-hydroxylase in the liver to form 25(OH)D, which is calcifediol, and then hydroxylated by 1α-hydroxylase in the kidney to form 1, 25-(OH)2D3, calcitriol, can exert its physiological regulatory function. Therefore, calcifediol and calcitriol are called the active forms of vitamin D, that is, active vitamin D.
The global Active Vitamin D market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Active Vitamin D is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Active Vitamin D is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Active Vitamin D in Orthopedic Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Active Vitamin D include Roche, Teijin Pharma, LEO Pharma, Abbot, Genzyme Corporation, Abbive, Nanjing Heron Pharmaceutical Science And Technology, Chengdu Gowell Biopharmaceutial and Chongqing Huapont Shengchem Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Active Vitamin D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Vitamin D.

Report Scope

The Active Vitamin D market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Active Vitamin D market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Active Vitamin D companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Active Vitamin D Market Report

Report Metric Details
Report Name Active Vitamin D Market
Segment by Type
  • Directly Effective
  • Takes Effect After Renal Metabolism
  • Takes Effect After Hepatic Metabolism
  • Other
Segment by Application
  • Orthopedic Diseases
  • Endocrine Diseases
  • Skin Diseases
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Teijin Pharma, LEO Pharma, Abbot, Genzyme Corporation, Abbive, Nanjing Heron Pharmaceutical Science And Technology, Chengdu Gowell Biopharmaceutial, Chongqing Huapont Shengchem Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Taifeng, China Resources Double-crane Pharmaceutical, SICHUAN KELUN PHARMACEUTICAL, Shandong Xinshidai, Nanjing Haijing Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Active Vitamin D companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Active Vitamin D Market report?

Ans: The main players in the Active Vitamin D Market are Roche, Teijin Pharma, LEO Pharma, Abbot, Genzyme Corporation, Abbive, Nanjing Heron Pharmaceutical Science And Technology, Chengdu Gowell Biopharmaceutial, Chongqing Huapont Shengchem Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Taifeng, China Resources Double-crane Pharmaceutical, SICHUAN KELUN PHARMACEUTICAL, Shandong Xinshidai, Nanjing Haijing Pharmaceutical

What are the Application segmentation covered in the Active Vitamin D Market report?

Ans: The Applications covered in the Active Vitamin D Market report are Orthopedic Diseases, Endocrine Diseases, Skin Diseases, Other

What are the Type segmentation covered in the Active Vitamin D Market report?

Ans: The Types covered in the Active Vitamin D Market report are Directly Effective, Takes Effect After Renal Metabolism, Takes Effect After Hepatic Metabolism, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Active Vitamin D Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Directly Effective
1.2.3 Takes Effect After Renal Metabolism
1.2.4 Takes Effect After Hepatic Metabolism
1.2.5 Other
1.3 Market by Application
1.3.1 Global Active Vitamin D Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Orthopedic Diseases
1.3.3 Endocrine Diseases
1.3.4 Skin Diseases
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Active Vitamin D Market Perspective (2019-2030)
2.2 Active Vitamin D Growth Trends by Region
2.2.1 Global Active Vitamin D Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Active Vitamin D Historic Market Size by Region (2019-2024)
2.2.3 Active Vitamin D Forecasted Market Size by Region (2025-2030)
2.3 Active Vitamin D Market Dynamics
2.3.1 Active Vitamin D Industry Trends
2.3.2 Active Vitamin D Market Drivers
2.3.3 Active Vitamin D Market Challenges
2.3.4 Active Vitamin D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Active Vitamin D Players by Revenue
3.1.1 Global Top Active Vitamin D Players by Revenue (2019-2024)
3.1.2 Global Active Vitamin D Revenue Market Share by Players (2019-2024)
3.2 Global Active Vitamin D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Active Vitamin D Revenue
3.4 Global Active Vitamin D Market Concentration Ratio
3.4.1 Global Active Vitamin D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Active Vitamin D Revenue in 2023
3.5 Active Vitamin D Key Players Head office and Area Served
3.6 Key Players Active Vitamin D Product Solution and Service
3.7 Date of Enter into Active Vitamin D Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Active Vitamin D Breakdown Data by Type
4.1 Global Active Vitamin D Historic Market Size by Type (2019-2024)
4.2 Global Active Vitamin D Forecasted Market Size by Type (2025-2030)
5 Active Vitamin D Breakdown Data by Application
5.1 Global Active Vitamin D Historic Market Size by Application (2019-2024)
5.2 Global Active Vitamin D Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Active Vitamin D Market Size (2019-2030)
6.2 North America Active Vitamin D Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Active Vitamin D Market Size by Country (2019-2024)
6.4 North America Active Vitamin D Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Active Vitamin D Market Size (2019-2030)
7.2 Europe Active Vitamin D Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Active Vitamin D Market Size by Country (2019-2024)
7.4 Europe Active Vitamin D Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Active Vitamin D Market Size (2019-2030)
8.2 Asia-Pacific Active Vitamin D Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Active Vitamin D Market Size by Region (2019-2024)
8.4 Asia-Pacific Active Vitamin D Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Active Vitamin D Market Size (2019-2030)
9.2 Latin America Active Vitamin D Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Active Vitamin D Market Size by Country (2019-2024)
9.4 Latin America Active Vitamin D Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Active Vitamin D Market Size (2019-2030)
10.2 Middle East & Africa Active Vitamin D Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Active Vitamin D Market Size by Country (2019-2024)
10.4 Middle East & Africa Active Vitamin D Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Active Vitamin D Introduction
11.1.4 Roche Revenue in Active Vitamin D Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Teijin Pharma
11.2.1 Teijin Pharma Company Detail
11.2.2 Teijin Pharma Business Overview
11.2.3 Teijin Pharma Active Vitamin D Introduction
11.2.4 Teijin Pharma Revenue in Active Vitamin D Business (2019-2024)
11.2.5 Teijin Pharma Recent Development
11.3 LEO Pharma
11.3.1 LEO Pharma Company Detail
11.3.2 LEO Pharma Business Overview
11.3.3 LEO Pharma Active Vitamin D Introduction
11.3.4 LEO Pharma Revenue in Active Vitamin D Business (2019-2024)
11.3.5 LEO Pharma Recent Development
11.4 Abbot
11.4.1 Abbot Company Detail
11.4.2 Abbot Business Overview
11.4.3 Abbot Active Vitamin D Introduction
11.4.4 Abbot Revenue in Active Vitamin D Business (2019-2024)
11.4.5 Abbot Recent Development
11.5 Genzyme Corporation
11.5.1 Genzyme Corporation Company Detail
11.5.2 Genzyme Corporation Business Overview
11.5.3 Genzyme Corporation Active Vitamin D Introduction
11.5.4 Genzyme Corporation Revenue in Active Vitamin D Business (2019-2024)
11.5.5 Genzyme Corporation Recent Development
11.6 Abbive
11.6.1 Abbive Company Detail
11.6.2 Abbive Business Overview
11.6.3 Abbive Active Vitamin D Introduction
11.6.4 Abbive Revenue in Active Vitamin D Business (2019-2024)
11.6.5 Abbive Recent Development
11.7 Nanjing Heron Pharmaceutical Science And Technology
11.7.1 Nanjing Heron Pharmaceutical Science And Technology Company Detail
11.7.2 Nanjing Heron Pharmaceutical Science And Technology Business Overview
11.7.3 Nanjing Heron Pharmaceutical Science And Technology Active Vitamin D Introduction
11.7.4 Nanjing Heron Pharmaceutical Science And Technology Revenue in Active Vitamin D Business (2019-2024)
11.7.5 Nanjing Heron Pharmaceutical Science And Technology Recent Development
11.8 Chengdu Gowell Biopharmaceutial
11.8.1 Chengdu Gowell Biopharmaceutial Company Detail
11.8.2 Chengdu Gowell Biopharmaceutial Business Overview
11.8.3 Chengdu Gowell Biopharmaceutial Active Vitamin D Introduction
11.8.4 Chengdu Gowell Biopharmaceutial Revenue in Active Vitamin D Business (2019-2024)
11.8.5 Chengdu Gowell Biopharmaceutial Recent Development
11.9 Chongqing Huapont Shengchem Pharmaceutical
11.9.1 Chongqing Huapont Shengchem Pharmaceutical Company Detail
11.9.2 Chongqing Huapont Shengchem Pharmaceutical Business Overview
11.9.3 Chongqing Huapont Shengchem Pharmaceutical Active Vitamin D Introduction
11.9.4 Chongqing Huapont Shengchem Pharmaceutical Revenue in Active Vitamin D Business (2019-2024)
11.9.5 Chongqing Huapont Shengchem Pharmaceutical Recent Development
11.10 Jiangsu Hengrui Pharmaceuticals
11.10.1 Jiangsu Hengrui Pharmaceuticals Company Detail
11.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.10.3 Jiangsu Hengrui Pharmaceuticals Active Vitamin D Introduction
11.10.4 Jiangsu Hengrui Pharmaceuticals Revenue in Active Vitamin D Business (2019-2024)
11.10.5 Jiangsu Hengrui Pharmaceuticals Recent Development
11.11 Taifeng
11.11.1 Taifeng Company Detail
11.11.2 Taifeng Business Overview
11.11.3 Taifeng Active Vitamin D Introduction
11.11.4 Taifeng Revenue in Active Vitamin D Business (2019-2024)
11.11.5 Taifeng Recent Development
11.12 China Resources Double-crane Pharmaceutical
11.12.1 China Resources Double-crane Pharmaceutical Company Detail
11.12.2 China Resources Double-crane Pharmaceutical Business Overview
11.12.3 China Resources Double-crane Pharmaceutical Active Vitamin D Introduction
11.12.4 China Resources Double-crane Pharmaceutical Revenue in Active Vitamin D Business (2019-2024)
11.12.5 China Resources Double-crane Pharmaceutical Recent Development
11.13 SICHUAN KELUN PHARMACEUTICAL
11.13.1 SICHUAN KELUN PHARMACEUTICAL Company Detail
11.13.2 SICHUAN KELUN PHARMACEUTICAL Business Overview
11.13.3 SICHUAN KELUN PHARMACEUTICAL Active Vitamin D Introduction
11.13.4 SICHUAN KELUN PHARMACEUTICAL Revenue in Active Vitamin D Business (2019-2024)
11.13.5 SICHUAN KELUN PHARMACEUTICAL Recent Development
11.14 Shandong Xinshidai
11.14.1 Shandong Xinshidai Company Detail
11.14.2 Shandong Xinshidai Business Overview
11.14.3 Shandong Xinshidai Active Vitamin D Introduction
11.14.4 Shandong Xinshidai Revenue in Active Vitamin D Business (2019-2024)
11.14.5 Shandong Xinshidai Recent Development
11.15 Nanjing Haijing Pharmaceutical
11.15.1 Nanjing Haijing Pharmaceutical Company Detail
11.15.2 Nanjing Haijing Pharmaceutical Business Overview
11.15.3 Nanjing Haijing Pharmaceutical Active Vitamin D Introduction
11.15.4 Nanjing Haijing Pharmaceutical Revenue in Active Vitamin D Business (2019-2024)
11.15.5 Nanjing Haijing Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Active Vitamin D Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Directly Effective
    Table 3. Key Players of Takes Effect After Renal Metabolism
    Table 4. Key Players of Takes Effect After Hepatic Metabolism
    Table 5. Key Players of Other
    Table 6. Global Active Vitamin D Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Active Vitamin D Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Active Vitamin D Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Active Vitamin D Market Share by Region (2019-2024)
    Table 10. Global Active Vitamin D Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Active Vitamin D Market Share by Region (2025-2030)
    Table 12. Active Vitamin D Market Trends
    Table 13. Active Vitamin D Market Drivers
    Table 14. Active Vitamin D Market Challenges
    Table 15. Active Vitamin D Market Restraints
    Table 16. Global Active Vitamin D Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Active Vitamin D Market Share by Players (2019-2024)
    Table 18. Global Top Active Vitamin D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Vitamin D as of 2023)
    Table 19. Ranking of Global Top Active Vitamin D Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Active Vitamin D Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Active Vitamin D Product Solution and Service
    Table 23. Date of Enter into Active Vitamin D Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Active Vitamin D Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Active Vitamin D Revenue Market Share by Type (2019-2024)
    Table 27. Global Active Vitamin D Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Active Vitamin D Revenue Market Share by Type (2025-2030)
    Table 29. Global Active Vitamin D Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Active Vitamin D Revenue Market Share by Application (2019-2024)
    Table 31. Global Active Vitamin D Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Active Vitamin D Revenue Market Share by Application (2025-2030)
    Table 33. North America Active Vitamin D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Active Vitamin D Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Active Vitamin D Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Active Vitamin D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Active Vitamin D Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Active Vitamin D Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Active Vitamin D Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Active Vitamin D Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Active Vitamin D Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Active Vitamin D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Active Vitamin D Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Active Vitamin D Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Active Vitamin D Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Active Vitamin D Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Active Vitamin D Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Roche Company Detail
    Table 49. Roche Business Overview
    Table 50. Roche Active Vitamin D Product
    Table 51. Roche Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 52. Roche Recent Development
    Table 53. Teijin Pharma Company Detail
    Table 54. Teijin Pharma Business Overview
    Table 55. Teijin Pharma Active Vitamin D Product
    Table 56. Teijin Pharma Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 57. Teijin Pharma Recent Development
    Table 58. LEO Pharma Company Detail
    Table 59. LEO Pharma Business Overview
    Table 60. LEO Pharma Active Vitamin D Product
    Table 61. LEO Pharma Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 62. LEO Pharma Recent Development
    Table 63. Abbot Company Detail
    Table 64. Abbot Business Overview
    Table 65. Abbot Active Vitamin D Product
    Table 66. Abbot Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 67. Abbot Recent Development
    Table 68. Genzyme Corporation Company Detail
    Table 69. Genzyme Corporation Business Overview
    Table 70. Genzyme Corporation Active Vitamin D Product
    Table 71. Genzyme Corporation Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 72. Genzyme Corporation Recent Development
    Table 73. Abbive Company Detail
    Table 74. Abbive Business Overview
    Table 75. Abbive Active Vitamin D Product
    Table 76. Abbive Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 77. Abbive Recent Development
    Table 78. Nanjing Heron Pharmaceutical Science And Technology Company Detail
    Table 79. Nanjing Heron Pharmaceutical Science And Technology Business Overview
    Table 80. Nanjing Heron Pharmaceutical Science And Technology Active Vitamin D Product
    Table 81. Nanjing Heron Pharmaceutical Science And Technology Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 82. Nanjing Heron Pharmaceutical Science And Technology Recent Development
    Table 83. Chengdu Gowell Biopharmaceutial Company Detail
    Table 84. Chengdu Gowell Biopharmaceutial Business Overview
    Table 85. Chengdu Gowell Biopharmaceutial Active Vitamin D Product
    Table 86. Chengdu Gowell Biopharmaceutial Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 87. Chengdu Gowell Biopharmaceutial Recent Development
    Table 88. Chongqing Huapont Shengchem Pharmaceutical Company Detail
    Table 89. Chongqing Huapont Shengchem Pharmaceutical Business Overview
    Table 90. Chongqing Huapont Shengchem Pharmaceutical Active Vitamin D Product
    Table 91. Chongqing Huapont Shengchem Pharmaceutical Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 92. Chongqing Huapont Shengchem Pharmaceutical Recent Development
    Table 93. Jiangsu Hengrui Pharmaceuticals Company Detail
    Table 94. Jiangsu Hengrui Pharmaceuticals Business Overview
    Table 95. Jiangsu Hengrui Pharmaceuticals Active Vitamin D Product
    Table 96. Jiangsu Hengrui Pharmaceuticals Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 97. Jiangsu Hengrui Pharmaceuticals Recent Development
    Table 98. Taifeng Company Detail
    Table 99. Taifeng Business Overview
    Table 100. Taifeng Active Vitamin D Product
    Table 101. Taifeng Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 102. Taifeng Recent Development
    Table 103. China Resources Double-crane Pharmaceutical Company Detail
    Table 104. China Resources Double-crane Pharmaceutical Business Overview
    Table 105. China Resources Double-crane Pharmaceutical Active Vitamin D Product
    Table 106. China Resources Double-crane Pharmaceutical Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 107. China Resources Double-crane Pharmaceutical Recent Development
    Table 108. SICHUAN KELUN PHARMACEUTICAL Company Detail
    Table 109. SICHUAN KELUN PHARMACEUTICAL Business Overview
    Table 110. SICHUAN KELUN PHARMACEUTICAL Active Vitamin D Product
    Table 111. SICHUAN KELUN PHARMACEUTICAL Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 112. SICHUAN KELUN PHARMACEUTICAL Recent Development
    Table 113. Shandong Xinshidai Company Detail
    Table 114. Shandong Xinshidai Business Overview
    Table 115. Shandong Xinshidai Active Vitamin D Product
    Table 116. Shandong Xinshidai Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 117. Shandong Xinshidai Recent Development
    Table 118. Nanjing Haijing Pharmaceutical Company Detail
    Table 119. Nanjing Haijing Pharmaceutical Business Overview
    Table 120. Nanjing Haijing Pharmaceutical Active Vitamin D Product
    Table 121. Nanjing Haijing Pharmaceutical Revenue in Active Vitamin D Business (2019-2024) & (US$ Million)
    Table 122. Nanjing Haijing Pharmaceutical Recent Development
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Active Vitamin D Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Active Vitamin D Market Share by Type: 2023 VS 2030
    Figure 3. Directly Effective Features
    Figure 4. Takes Effect After Renal Metabolism Features
    Figure 5. Takes Effect After Hepatic Metabolism Features
    Figure 6. Other Features
    Figure 7. Global Active Vitamin D Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Active Vitamin D Market Share by Application: 2023 VS 2030
    Figure 9. Orthopedic Diseases Case Studies
    Figure 10. Endocrine Diseases Case Studies
    Figure 11. Skin Diseases Case Studies
    Figure 12. Other Case Studies
    Figure 13. Active Vitamin D Report Years Considered
    Figure 14. Global Active Vitamin D Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Active Vitamin D Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Active Vitamin D Market Share by Region: 2023 VS 2030
    Figure 17. Global Active Vitamin D Market Share by Players in 2023
    Figure 18. Global Top Active Vitamin D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Vitamin D as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Active Vitamin D Revenue in 2023
    Figure 20. North America Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Active Vitamin D Market Share by Country (2019-2030)
    Figure 22. United States Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Active Vitamin D Market Share by Country (2019-2030)
    Figure 26. Germany Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Active Vitamin D Market Share by Region (2019-2030)
    Figure 34. China Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Active Vitamin D Market Share by Country (2019-2030)
    Figure 42. Mexico Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Active Vitamin D Market Share by Country (2019-2030)
    Figure 46. Turkey Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Active Vitamin D Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Roche Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 49. Teijin Pharma Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 50. LEO Pharma Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 51. Abbot Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 52. Genzyme Corporation Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 53. Abbive Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 54. Nanjing Heron Pharmaceutical Science And Technology Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 55. Chengdu Gowell Biopharmaceutial Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 56. Chongqing Huapont Shengchem Pharmaceutical Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 57. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 58. Taifeng Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 59. China Resources Double-crane Pharmaceutical Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 60. SICHUAN KELUN PHARMACEUTICAL Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 61. Shandong Xinshidai Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 62. Nanjing Haijing Pharmaceutical Revenue Growth Rate in Active Vitamin D Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Y1251
Thu Sep 11 00:00:00 UTC 2025

Add to Cart